We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-1.13%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$103B
AUM Growth
+$1.83B
Cap. Flow
+$3.67B
Cap. Flow %
3.57%
Top 10 Hldgs %
46.02%
Holding
3,718
New
534
Increased
1,981
Reduced
979
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 7.11%
2 Financials 3.31%
3 Consumer Discretionary 2.07%
4 Healthcare 1.66%
5 Communication Services 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTU
3176
Optimum Communications Inc
OPTU
$297M
$86K ﹤0.01%
35,678
-21,938
-38% -$54.8K
CHPT icon
3177
ChargePoint
CHPT
$136M
$84.3K ﹤0.01%
3,938
-6,312
-62% -$156K
EVGO icon
3178
EVgo
EVGO
$223M
$83.7K ﹤0.01%
20,674
+7,309
+55% +$46.5K
LAB icon
3179
Standard BioTools
LAB
$330M
$82.7K ﹤0.01%
47,278
+26,950
+133% +$50.2K
RCS
3180
PIMCO Strategic Income Fund
RCS
$243M
$82.7K ﹤0.01%
+10,847
New +$83.1K
EVLV icon
3181
Evolv Technologies
EVLV
$1B
$81.9K ﹤0.01%
+20,744
New +$72.8K
VMEO
3182
DELISTED
Vimeo
VMEO
$81.9K ﹤0.01%
+12,794
New +$77K
ARDX icon
3183
Ardelyx
ARDX
$1.25B
$81.2K ﹤0.01%
16,010
-3,732
-19% -$20.6K
NEXT icon
3184
NextDecade
NEXT
$1.69B
$81.1K ﹤0.01%
+10,521
New +$67.4K
PRME icon
3185
Prime Medicine
PRME
$538M
$80.7K ﹤0.01%
+27,623
New +$97K
SWIM icon
3186
Latham Group
SWIM
$647M
$80.3K ﹤0.01%
11,540
+125
+1% +$836
LZ icon
3187
LegalZoom.com
LZ
$1.44B
$78.8K ﹤0.01%
10,487
-820
-7% -$6.18K
LESL icon
3188
Leslie's
LESL
$8.62M
$77.7K ﹤0.01%
1,741
+524
+43% +$27.8K
DCGO icon
3189
DocGo
DCGO
$66.7M
$77.5K ﹤0.01%
+18,278
New +$70.4K
DDD icon
3190
3D Systems Corp
DDD
$400M
$77.4K ﹤0.01%
23,612
+8,638
+58% +$27.5K
CDLX icon
3191
Cardlytics
CDLX
$22.2M
$77.4K ﹤0.01%
2,087
-867
-29% -$33.2K
ESPR
3192
DELISTED
Esperion Therapeutics
ESPR
$77K ﹤0.01%
34,989
+11,756
+51% +$27.4K
ANNX icon
3193
Annexon
ANNX
$791M
$75.3K ﹤0.01%
14,673
-20,106
-58% -$124K
OXLC
3194
Oxford Lane Capital
OXLC
$866M
$75K ﹤0.01%
2,958
-3,512
-54% -$92K
CVBF icon
3195
CVB Financial
CVBF
$4.02B
$74.9K ﹤0.01%
+3,500
New +$74K
AVIR icon
3196
Atea Pharmaceuticals
AVIR
$372M
$74.8K ﹤0.01%
+22,341
New +$74.2K
GGT
3197
Gabelli Multimedia Trust
GGT
$169M
$74.3K ﹤0.01%
16,665
+4,531
+37% +$21.7K
OLPX
3198
DELISTED
Olaplex Holdings
OLPX
$73.7K ﹤0.01%
42,593
-3,004
-7% -$5.98K
ARRY icon
3199
Array Technologies
ARRY
$752M
$73.5K ﹤0.01%
12,161
-14,494
-54% -$92.4K
BFLY icon
3200
Butterfly Network
BFLY
$1.86B
$73.1K ﹤0.01%
23,425
+5,201
+29% +$13.5K

Similar funds

Creative Planning's Q4 2024 Portfolio in Review

As of Q4 2024, Creative Planning held 3,718 positions worth $103B, up 1.8% from $101B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Creative Planning deployed $3.67B of net new capital in Q4 2024, opening 534 new positions and adding to 1,981 existing holdings. Its largest new stake was VanEck IG Floating Rate ETF: 1,040,413 shares worth $26.5M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, an estimated $213M trimmed.

  • Creative Planning's largest Q4 2024 buy was VanEck IG Floating Rate ETF: 1,040,413 shares worth $26.5M.
  • Creative Planning added most to Vanguard Total Bond Market in Q4 2024, an estimated $649M increase.
  • Creative Planning's biggest Q4 2024 reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, cutting an estimated $213M.
  • Creative Planning fully exited iShares iBonds Dec 2024 Term Treasury ETF in Q4 2024, selling an estimated $4.5M.
  • Creative Planning's ten largest holdings make up 46% of its $103B portfolio in Q4 2024.
  • Creative Planning opened 534 new positions and closed 136 in Q4 2024.
  • Creative Planning's portfolio value rose 1.8% quarter-over-quarter to $103B.

Based on Creative Planning's 13F filing for Q4 2024, filed 14 Feb 2025.